From diagnosis to treatment of minimal change disease in pregnancy

Petra Bolt1, Iana Adamović2, Matija Horaček2

  • 1University of Zagreb School of Medicine, Šalata 2, 10000, Zagreb, Croatia. petra.bolt@gmail.com.

CEN Case Reports
|May 5, 2025
PubMed

Preeclampsia accounts for the majority of nephrotic syndrome in pregnancy. However, primary renal diseases, although not as common, can also be the cause. The authors report a case of a 33-year-old pregnant woman at 22 weeks of gestation who presented with significant proteinuria, hypoalbuminemia, hyperlipidemia and discrete pitting edema. After the initial workup, a kidney biopsy was performed to diagnose minimal change disease (MCD), which revealed extensive podocyte foot process effacement. Treatment with IV methylprednisolone followed by oral prednisone led to remission, but a relapse occurred at 37 weeks of gestation. Labor was induced due to oligohydramnios with fetal growth restriction and a female hypotrophic neonate was delivered. Later on, the neonate developed sepsis and was successfully treated. Postpartum, the mother acquired a steroid resistance, and tacrolimus was used to achieve complete remission. In this case report, we emphasize the importance of kidney biopsy in adequately diagnosing primary renal diseases, even in pregnancy. This greatly helps clinicians in choosing the appropriate therapy for the patient, leading to disease remission.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
98
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
46
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
219
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
84
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
79